Companies: 10,795·Total market cap: $144.5T
IBEX Technologies Inc.

IBEX Technologies Inc.

IBXNFOTCHealthcare
$1.00
$-0.07(-6.54%)
Market Cap$25270800
P/E Ratio
52W High$1.1
52W Low$0.56

IBEX Technologies Inc. (IBXNF) Shares Outstanding — Overview

Basic and diluted weighted average shares, YoY change, float context, and historical trend from SEC filings and FMP.

IBXNF · shares outstanding · updated Jun 8, 2026

Key metrics

Basic Shares Outstanding · Weighted average · fiscal year
24.8M -0.17% YoY Change
FY · as of Jul 31, 2023 · Reported in CAD
vs 24.8M in FY 2022
Diluted Shares Outstanding
24.8M
incl. options, RSUs, convertibles
Dilution Spread
+0.00%
Diluted vs Basic
YoY Change
-0.17%
year-over-year
Float (Free Float)
15.5M
publicly tradable shares
61.5% of total
Source: FMP /income-statement · /shares-float · SEC 10-K / 10-QUpdated: 2026-06-08

Shares Outstanding Growth Rate

3-Year CAGRincreasing
+0.0%
2020 → 2023
5-Year CAGRincreasing
+0.0%
2018 → 2023
10-Year CAGRincreasing
+0.0%
2013 → 2023

Negative CAGR typically indicates share buyback or retirement activity. Interpret alongside Splits and Financials tabs. Splits / Financials

Shares outstanding history

↓ Decrease — typically buyback / retirement
↑ Increase — issuance / equity compensation
Latest
* most recent reported · FMP /income-statement · weightedAverageShsOut

Annual shares outstanding by year

FY 2023Latest
Diluted Shares: 24.8M
24.8M
-0.17%
FY 2022
Diluted Shares: 24.8M
24.8M
+0.00%
FY 2021
Diluted Shares: 24.8M
24.8M
+0.20%
FY 2020
Diluted Shares: 24.8M
24.8M
+0.00%
FY 2019
Diluted Shares: 24.8M
24.8M
+0.00%
FMP /income-statement · weightedAverageShsOut · weightedAverageShsOutDilUnit: Billions (B)

Healthcare sector shares outstanding comparison

Shares Outstanding for similar companies or competitors in the Healthcare sector.

#SymbolCompanyShares (Basic)vs IBXNF
#1
Merck & Co., Inc.MRK
Merck & Co., Inc.
2.502B+>999%
#2
Johnson & JohnsonJNJ
Johnson & Johnson
2.429B+>999%
#3
AbbVie Inc.ABBV
AbbVie Inc.
1.780B+>999%
#4
AstraZeneca PLCAZN
AstraZeneca PLC
1.550B+>999%
#5
UnitedHealth Group IncorporatedUNH
UnitedHealth Group Incorporated
910.0M+>999%
#6
Eli Lilly and CompanyLLY
Eli Lilly and Company
898.0M+>999%
#7
IBEX Technologies Inc.IBXNF
IBEX Technologies Inc.YOU
24.8M

/company-screener · per-peer /income-statement · cache 86400s

Understanding Shares Outstanding

What Are Shares Outstanding? (Basic)

IBEX Technologies Inc. (IBXNF) shares outstanding is the total number of issued shares held by shareholders — the basis for Basic EPS and market capitalization. As of July 31, 2023, IBEX Technologies Inc. reports 24.8M basic shares outstanding (weighted average).

Basic vs. Diluted Shares Outstanding

IBEX Technologies Inc.'s basic shares outstanding (24.8M) represents currently issued shares. Diluted shares outstanding (24.8M) also includes potential shares from stock options, RSUs, and convertibles. Dilution spread: +0.00%.

Shares Outstanding vs. Float (Free Float)

IBEX Technologies Inc.'s float is 15.5M (61.5% of total shares outstanding) — shares freely available for public trading, excluding insider-held and restricted shares.

Float15.5M(61.5%)
Outstanding25.3M

Float data from /shares-float reflects the most recent SEC filing period-end. The weighted average shares (from /income-statement) may differ — this is a normal reporting window difference, not a data error.

FMP /income-statement · /shares-float · SEC EDGAR · CAD

About shares outstanding & methodology

IBEX Technologies Inc. (IBXNF) shares outstanding history from 2004 to 2023. Shares outstanding can be defined as the total number of shares held by all shareholders — including institutional investors, retail investors, and company insiders — assuming conversion of all convertible debt, securities, warrants, and options. This metric excludes the company's treasury shares.

IBEX Technologies Inc. shares outstanding for the fiscal year ending July 31, 2023 were 24.8M, a 0.17% decline year-over-year. IBEX Technologies Inc. FY 2023 shares outstanding were 24.8M, a -0.17% decline from FY 2022.

IBEX Technologies Inc. is a leading company operating in the Healthcare sector. The company's share count trajectory — with a 10-year CAGR of +0.0% — is a key signal for investors evaluating capital return policy, EPS accretion, and long-term shareholder value creation.

Figures tie to SEC 10-K/10-Q income statement disclosures and FMP /income-statement · /shares-float where noted.

Frequently asked questions

IBXNF shares outstanding · 4 questions

As of July 31, 2023, IBEX Technologies Inc. (IBXNF) has approximately 24.8M basic shares outstanding and 24.8M diluted shares outstanding. This represents a -0.17% year-over-year change from FY 2022 (24.8M). IBEX Technologies Inc.'s declining share count is primarily driven by its share buyback program. For the complete historical data table, see the history table above.

IBXNF shares outstandinghow many shares does IBXNF haveIBXNF basic shares 2023IBXNF diluted shares

Data: FMP /income-statement · /shares-float · SEC EDGAR · weighted average basis · IBEX Technologies Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: 2026-06-08